April 13, 2022
Sexual and Reproductive Health Drug Therapy | Osteoporosis
Sexual & Reproductive Health Drug Therapy 2020
Susan Ott, MD
Professor of Medicine, UW Medicine
Advanced practice nurse practitioners, especially adult, family, and sexual reproductive health nurse practitioners (including women’s health certified), clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Understand the risks of Denosumab, particularly hypocalcemia and rapid rebound bone loss.
- Describe the effectiveness of bisphosphonates as related to duration of use.
- Learn the benefits of estrogen in recently postmenopausal women.